GHEUENS SARAH (Chief Medical Officer) sold 3.5% of their position (2.94K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $102.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001439222-26-000065
Officer· Chief Medical Officer
Since Sep 2021
-2.94K
Net shares
Net seller
$102.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.50K acquired · 11.44K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+8.50K
Price / share
—
Trade value
—
% of position
11.4%
4/2/2026
74.72K→83.22K
Common stock
Direct
Shares
−2.94K
Price / share
$34.71
Trade value
$102.05K
% of position
3.5%
4/2/2026
83.22K→80.28K
Total
Net shares
+5.56K
Net value
-$102.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/2/2026 | M · Option Exercise | +8.50K | — | — | 11.4% | 74.72K | 83.22K |
| Common stock Direct | 4/2/2026 | S · Sale | −2.94K | $34.71 | $102.05K | 3.5% | 83.22K | 80.28K |
| Total | +5.56K | -$102.05K | ||||||
Derivative Transactions1
Performance share units
Direct
Converts to
Common stock
8.50K shares
Shares
−8.50K
Strike price
Held after
8.50K
Exercisable
—
4/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance share units Direct | Common stock8.50K shares | 4/2/2026 | M · Option Exercise | −8.50K | — | 8.50K |